Magellan Health Company Profile (NASDAQ:MGLN)

About Magellan Health (NASDAQ:MGLN)

Magellan Health logoMagellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NASDAQ:MGLN
  • CUSIP: 55907920
  • Web:
  • Market Cap: $1.99999 billion
  • Outstanding Shares: 23,683,000
Average Prices:
  • 50 Day Moving Avg: $83.14
  • 200 Day Moving Avg: $75.30
  • 52 Week Range: $49.50 - $88.10
  • Trailing P/E Ratio: 24.26
  • Foreward P/E Ratio: 15.27
  • P/E Growth: 0.91
Sales & Book Value:
  • Annual Revenue: $5.28 billion
  • Price / Sales: 0.38
  • Book Value: $48.29 per share
  • Price / Book: 1.76
  • EBITDA: $242.58 million
  • Net Margins: 1.59%
  • Return on Equity: 8.88%
  • Return on Assets: 4.08%
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 1.25%
  • Quick Ratio: 1.19%
  • Average Volume: 144,722 shs.
  • Beta: 0.58
  • Short Ratio: 2.33

Frequently Asked Questions for Magellan Health (NASDAQ:MGLN)

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) announced its quarterly earnings results on Friday, July, 28th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.94 by $0.48. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.40 billion. Magellan Health had a return on equity of 8.88% and a net margin of 1.59%. The company's quarterly revenue was up 21.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.58 EPS. View Magellan Health's Earnings History.

When will Magellan Health make its next earnings announcement?

Magellan Health is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for Magellan Health.

Where is Magellan Health's stock going? Where will Magellan Health's stock price be in 2017?

4 brokers have issued 12-month price objectives for Magellan Health's stock. Their predictions range from $69.00 to $94.00. On average, they expect Magellan Health's stock price to reach $81.25 in the next year. View Analyst Ratings for Magellan Health.

What are analysts saying about Magellan Health stock?

Here are some recent quotes from research analysts about Magellan Health stock:

  • 1. According to Zacks Investment Research, "Magellan Health Services is the country's leading behavioral managed care organization. Its customers include health plans, corporations and government agencies. " (10/4/2017)
  • 2. Jefferies Group LLC analysts commented, "We believe mixed 4Q results and a small EPS guidance reduction (share count related) on the heels of MGLN's 50%+ surge (vs S&P's +10%) since early November are causing shares to pull back today (down 7-8% vs S&P's -0.2%). 4Q16 revenue was soft, but that's largely due to a short delay in starting new work. We think fundamentals remain broadly strong and remain Buy rated, but we modestly reduce our earnings projections and PT for higher Pharmacy uncertainty." (2/24/2017)

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:

  • Barry Michael Smith, Executive Chairman of the Board, Chief Executive Officer
  • Mostafa Kamal, Chief Executive Officer of Magellan Rx Management
  • Sanjeev K. Srivastava, Chief Executive Officer - Magellan Healthcare
  • Caskie R. Lewis-Clapper, Chief Human Resource Officer
  • Daniel N. Gregoire, General Counsel, Secretary
  • William J. McBride, Lead Independent Director
  • John O. Agwunobi M.D., Independent Director
  • Eran Broshy, Independent Director
  • Michael S. Diament, Independent Director
  • Perry G. Fine M.D., Independent Director

Who owns Magellan Health stock?

Magellan Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Eqis Capital Management Inc. (0.03%). Company insiders that own Magellan Health stock include Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Who bought Magellan Health stock? Who is buying Magellan Health stock?

Magellan Health's stock was purchased by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Magellan Health.

How do I buy Magellan Health stock?

Shares of Magellan Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of Magellan Health stock can currently be purchased for approximately $85.20.

MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  190 (Vote Outperform)
Underperform Votes:  186 (Vote Underperform)
Total Votes:  376
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Magellan Health (NASDAQ:MGLN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $81.25 (4.64% downside)
Consensus Price Target History for Magellan Health (NASDAQ:MGLN)
Price Target History for Magellan Health (NASDAQ:MGLN)
Analysts' Ratings History for Magellan Health (NASDAQ:MGLN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/13/2017Jefferies Group LLCReiterated RatingBuy$94.00N/AView Rating Details
9/22/2017KeyCorpReiterated RatingBuy$89.00LowView Rating Details
6/25/2017Leerink SwannReiterated RatingOutperform$68.00 -> $73.00LowView Rating Details
11/23/2016Barclays PLCBoost Price TargetUnderweight$61.00 -> $69.00N/AView Rating Details
(Data available from 10/18/2015 forward)


Earnings History for Magellan Health (NASDAQ:MGLN)
Earnings by Quarter for Magellan Health (NASDAQ:MGLN)
Earnings History by Quarter for Magellan Health (NASDAQ MGLN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017$1.40N/AView Earnings Details
7/28/2017Q2 2017$0.94$0.46$1.40 billion$1.42 billionViewN/AView Earnings Details
4/26/2017Q1 2017$0.70$0.74$1.33 billion$1.31 billionViewN/AView Earnings Details
2/24/2017Q416$1.68$1.80$1.33 billion$1.26 billionViewN/AView Earnings Details
11/9/2016Q316$0.67$1.39$1.22 billion$1.29 billionViewListenView Earnings Details
7/29/2016Q216$0.62$0.58$1.15 billion$1.16 billionViewListenView Earnings Details
5/5/2016Q116$0.55$0.54$1.04 billion$1.12 billionViewN/AView Earnings Details
2/29/2016Q415$0.83$1.39$1.23 billion$1.27 billionViewListenView Earnings Details
10/27/2015Q315$0.49$0.53$1.19 billion$1.19 billionViewListenView Earnings Details
7/27/2015Q215$0.38$0.17$1.09 billion$1.16 billionViewListenView Earnings Details
4/30/2015Q115$0.38$0.73$1.02 billion$981.00 millionViewN/AView Earnings Details
2/26/2015Q414$0.49$1.04$980.37 million$982.50 millionViewListenView Earnings Details
10/24/2014Q314$0.44$1.09$930.10 million$823.20 millionViewListenView Earnings Details
7/25/2014Q214$0.56$0.25$863.10 million$888.00 millionViewListenView Earnings Details
4/29/2014Q114$0.75$0.92$1,000.00 million$966.50 millionViewListenView Earnings Details
3/3/2014Q413$0.83$0.67$990.55 million$1.01 millionViewN/AView Earnings Details
10/24/2013Q313$1.01$1.70$875.26 million$873.60 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.01$1.15$852.42 million$842.70 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.88$1.01$864.04 million$821.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$1.05$1.32$835.55 million$830.30 millionViewN/AView Earnings Details
10/26/2012Q312$0.96$1.12$845.16 million$798.40 millionViewN/AView Earnings Details
7/27/2012$0.91$0.97ViewN/AView Earnings Details
4/27/2012$0.90$0.75ViewN/AView Earnings Details
2/28/2012$0.77$1.05ViewN/AView Earnings Details
10/27/2011$0.84$1.03ViewN/AView Earnings Details
7/29/2011$0.86$1.07ViewN/AView Earnings Details
4/29/2011$0.79$1.02ViewN/AView Earnings Details
2/24/2011$0.91$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Magellan Health (NASDAQ:MGLN)
2017 EPS Consensus Estimate: $4.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.66$0.87$0.75
Q2 20173$0.85$0.92$0.89
Q3 20173$0.86$1.33$1.06
Q4 20173$1.44$1.62$1.56
(Data provided by Zacks Investment Research)


Dividend History for Magellan Health (NASDAQ:MGLN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Magellan Health (NASDAQ:MGLN)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 93.55%
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Institutional Ownership by Quarter for Magellan Health (NASDAQ:MGLN)
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2017Daniel N GregoireGeneral CounselSell12,475$88.02$1,098,049.50View SEC Filing  
10/3/2017Jeffrey N WestSVPSell30,021$87.31$2,621,133.51View SEC Filing  
10/2/2017Jeffrey N WestSVPSell19,007$86.22$1,638,783.54View SEC Filing  
9/29/2017Jeffrey N WestSVPSell18,511$86.18$1,595,277.98View SEC Filing  
9/28/2017Jeffrey N WestSVPSell25,316$85.85$2,173,378.60View SEC Filing  
9/28/2017Mostafa KamalCEOSell4,848$85.76$415,764.48View SEC Filing  
9/27/2017Daniel N GregoireGeneral CounselSell35,658$85.17$3,036,991.86View SEC Filing  
9/27/2017Jeffrey N WestSVPSell19,921$85.30$1,699,261.30View SEC Filing  
9/27/2017Mostafa KamalCEOSell19,126$85.33$1,632,021.58View SEC Filing  
9/15/2017Daniel N GregoireGeneral CounselSell20,465$83.05$1,699,618.25View SEC Filing  
9/15/2017Mostafa KamalCEOSell2,961$84.00$248,724.00View SEC Filing  
9/13/2017Daniel N GregoireGeneral CounselSell14,096$83.06$1,170,813.76View SEC Filing  
9/13/2017Mostafa KamalCEOSell604$83.00$50,132.00View SEC Filing  
9/11/2017Daniel N GregoireGeneral CounselSell2,400$83.00$199,200.00View SEC Filing  
9/11/2017Mostafa KamalCEOSell670$83.00$55,610.00View SEC Filing  
9/8/2017Mostafa KamalCEOSell6,267$81.53$510,948.51View SEC Filing  
9/7/2017Mostafa KamalCEOSell2,190$81.07$177,543.30View SEC Filing  
7/25/2017Daniel N GregoireGeneral CounselSell4,559$80.68$367,820.12View SEC Filing  
7/24/2017Daniel N GregoireGeneral CounselSell33,574$80.11$2,689,613.14View SEC Filing  
7/20/2017Daniel N GregoireGeneral CounselSell16,073$80.06$1,286,804.38View SEC Filing  
7/20/2017Jeffrey N WestSVPSell1,109$80.01$88,731.09View SEC Filing  
7/17/2017Jeffrey N WestSVPSell28,514$80.07$2,283,115.98View SEC Filing  
7/14/2017Daniel N GregoireGeneral CounselSell14,114$80.11$1,130,672.54View SEC Filing  
2/24/2017Jeffrey N WestSVPSell13,512$80.31$1,085,148.72View SEC Filing  
2/23/2017Eran BroshyDirectorSell4,867$80.00$389,360.00View SEC Filing  
2/3/2017Jeffrey N WestSVPSell15,055$76.46$1,151,105.30View SEC Filing  
2/1/2017Jeffrey N WestSVPSell3,346$76.05$254,463.30View SEC Filing  
12/8/2016Clapper Caskie LewisInsiderSell55,590$74.43$4,137,563.70View SEC Filing  
12/7/2016Jonathan N RubinCFOSell42,966$73.27$3,148,118.82View SEC Filing  
12/5/2016Jonathan N RubinCFOSell1,600$73.05$116,880.00View SEC Filing  
12/1/2016Jonathan N RubinCFOSell1,150$73.23$84,214.50View SEC Filing  
11/30/2016Jonathan N RubinCFOSell7,620$73.01$556,336.20View SEC Filing  
11/29/2016Jonathan N RubinCFOSell7,177$73.01$523,992.77View SEC Filing  
7/12/2016Jeffrey N WestSVPBuy267$51.99$13,881.33View SEC Filing  
1/15/2016Jeffrey N WestSVPBuy105$52.41$5,503.05View SEC Filing  
7/15/2015Jeffrey N WestSVPBuy298$50.22$14,965.56View SEC Filing  
3/19/2015Daniel N GregoireGeneral CounselSell26,232$68.47$1,796,105.04View SEC Filing  
3/16/2015Daniel N GregoireGeneral CounselSell15,528$66.80$1,037,270.40View SEC Filing  
3/16/2015Jonathan N RubinCFOSell21,270$66.59$1,416,369.30View SEC Filing  
3/13/2015Daniel N GregoireGeneral CounselSell9,765$66.21$646,540.65View SEC Filing  
3/2/2015Daniel N GregoireGeneral CounselSell20,365$64.48$1,313,135.20View SEC Filing  
6/30/2014Daniel N GregoireGeneral CounselSell21,675$62.25$1,349,268.75View SEC Filing  
6/26/2014Jonathan N RubinCFOSell29,700$61.92$1,839,024.00View SEC Filing  
6/25/2014Jonathan N RubinCFOSell18,400$62.40$1,148,160.00View SEC Filing  
6/24/2014Jonathan N RubinCFOSell19,200$62.46$1,199,232.00View SEC Filing  
6/23/2014Jonathan N RubinCFOSell21,700$62.73$1,361,241.00View SEC Filing  
6/20/2014Jonathan N RubinCFOSell31,200$62.99$1,965,288.00View SEC Filing  
6/19/2014Jonathan N RubinCFOSell18,600$62.73$1,166,778.00View SEC Filing  
6/18/2014Jonathan N RubinCFOSell35,896$62.79$2,253,909.84View SEC Filing  
6/17/2014Jonathan N RubinCFOSell23,996$62.22$1,493,031.12View SEC Filing  
6/16/2014Jonathan N RubinCFOSell13,041$62.18$810,889.38View SEC Filing  
6/16/2014Tina BlasiCEOSell10,775$62.07$668,804.25View SEC Filing  
6/13/2014Tina BlasiCEOSell10,247$62.03$635,621.41View SEC Filing  
5/19/2014Barry SmithCEOBuy10,000$58.56$585,600.00View SEC Filing  
5/14/2014Robert LeblancDirectorBuy10,000$55.60$556,000.00View SEC Filing  
3/6/2014Tina BlasiCEOSell10,527$60.42$636,041.34View SEC Filing  
12/20/2013Daniel GregoireGeneral CounselSell10,631$58.00$616,598.00View SEC Filing  
12/3/2013Rene LererChairmanSell28,321$61.01$1,727,864.21View SEC Filing  
12/2/2013Rene LererChairmanSell36,000$61.30$2,206,800.00View SEC Filing  
11/26/2013Rene LererChairmanSell5,055$60.75$307,091.25View SEC Filing  
11/22/2013Rene LererChairmanSell14,700$60.67$891,849.00View SEC Filing  
11/18/2013Rene LererChairmanSell33,215$61.34$2,037,408.10View SEC Filing  
11/14/2013Rene LererDirectorSell52,541$59.99$3,151,934.59View SEC Filing  
11/12/2013Rene LererChairmanSell36,500$59.34$2,165,910.00View SEC Filing  
11/8/2013Rene LererChairmanSell15,200$59.62$906,224.00View SEC Filing  
11/6/2013Rene LererChairmanSell96,773$59.27$5,735,735.71View SEC Filing  
11/4/2013Rene LererChairmanSell62,900$59.01$3,711,729.00View SEC Filing  
10/24/2013Tina BlasiCEOSell12,331$62.00$764,522.00View SEC Filing  
7/11/2013Jonathan N RubinCFOSell24,500$57.53$1,409,485.00View SEC Filing  
7/9/2013Jonathan N RubinCFOSell27,950$57.92$1,618,864.00View SEC Filing  
7/8/2013Jonathan N RubinCFOSell6,150$57.05$350,857.50View SEC Filing  
6/19/2013Jonathan N RubinCFOSell1,600$57.06$91,296.00View SEC Filing  
6/3/2013Clapper Caskie LewisInsiderSell43,399$55.00$2,386,945.00View SEC Filing  
5/31/2013Clapper Caskie LewisInsiderSell14,002$55.00$770,110.00View SEC Filing  
10/5/2012Tina BlasiCEOSell3,000$52.06$156,180.00View SEC Filing  
10/3/2012Tina BlasiCEOSell1,955$52.03$101,718.65View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Magellan Health (NASDAQ:MGLN)
Latest Headlines for Magellan Health (NASDAQ:MGLN)
DateHeadline logoComparing Magellan Health (MGLN) and Its Peers - October 18 at 12:36 PM logoCritical Analysis: Magellan Health (MGLN) & Its Rivals - October 16 at 8:30 PM logoMagellan Health, Inc. (MGLN) Receives Buy Rating from Jefferies Group LLC - October 14 at 7:40 AM logoMagellan Health, Inc. (MGLN) Receives Consensus Rating of "Buy" from Analysts - October 12 at 4:48 PM logoCorporate News Blog - Magellan Health Announces the Receipt of All Necessary Regulatory Approvals for Acquiring Senior Whole Health - October 12 at 6:51 AM logoMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by California Wildfires - October 10 at 8:17 PM logoMagellan Health (MGLN) & The Competition Financial Survey - October 9 at 6:28 PM logoMagellan Health Receives Regulatory Approvals to Acquire Senior Whole Health - October 9 at 4:07 PM logoReviewing Magellan Health (MGLN) and The Competition - October 8 at 6:30 AM logoMagellan Health (MGLN) versus Its Competitors Head-To-Head Contrast - October 5 at 8:24 PM logoInsider Selling: Magellan Health, Inc. (MGLN) General Counsel Sells 12,475 Shares of Stock - October 5 at 1:28 PM logo$1.49 Billion in Sales Expected for Magellan Health, Inc. (MGLN) This Quarter - October 5 at 3:38 AM logoMagellan Health, Inc. (MGLN) SVP Jeffrey N. West Sells 30,021 Shares - October 4 at 7:20 PM logoInsider Selling: Magellan Health, Inc. (MGLN) SVP Sells 19,007 Shares of Stock - October 3 at 10:28 PM logoMagellan Health, Inc. (MGLN) SVP Jeffrey N. West Sells 18,511 Shares - October 3 at 10:28 PM logoMagellan Health, Inc. (MGLN) Expected to Announce Earnings of $1.46 Per Share - October 3 at 6:20 PM logoMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by Mass Shooting in Las Vegas - October 2 at 11:53 AM logoComparing Magellan Health (MGLN) & Anthem (ANTM) - October 1 at 12:08 AM logoMagellan Health Services (MGLN) Presents At Cantor Fitzgerald Global Healthcare Conference - Slideshow - September 29 at 11:37 PM logoMagellan Health, Inc. (MGLN) SVP Sells $2,173,378.60 in Stock - September 29 at 7:16 PM logoJeffrey N. West Sells 19,921 Shares of Magellan Health, Inc. (MGLN) Stock - September 29 at 7:16 PM logoInsider Selling: Magellan Health, Inc. (MGLN) CEO Sells 4,848 Shares of Stock - September 29 at 1:32 PM logoMagellan Health, Inc. (MGLN) General Counsel Sells $3,036,991.86 in Stock - September 28 at 4:34 PM logoMagellan Health, Inc. (MGLN) CEO Mostafa Kamal Sells 19,126 Shares - September 28 at 4:34 PM logoMagellan Health Announces Closing of $400 Million of 4.40 Percent Senior Notes Due 2024 and Refinancing of Senior ... - Business Wire (press release) - September 27 at 3:43 PM logoMagellan Health Announces Closing of $400 Million of 4.40 Percent Senior Notes Due 2024 and Refinancing of Senior Credit Facility - September 25 at 8:23 AM logoKeyCorp Reaffirms "Buy" Rating for Magellan Health, Inc. (MGLN) - September 22 at 6:58 AM logoReviewing Centene Corporation (CNC) & Magellan Health (MGLN) - September 19 at 8:52 AM logoMagellan Health, Inc. (MGLN) CEO Mostafa Kamal Sells 2,961 Shares - September 18 at 4:16 PM logoMagellan Health, Inc. (MGLN) General Counsel Sells $1,699,618.25 in Stock - September 18 at 1:16 PM logoMagellan Health, Inc. (MGLN) Receives Consensus Rating of "Buy" from Brokerages - September 17 at 2:48 PM logoMagellan Health, Inc. (MGLN) Expected to Announce Quarterly Sales of $1.49 Billion - September 16 at 1:38 AM logoInsider Selling: Magellan Health, Inc. (MGLN) CEO Sells 604 Shares of Stock - September 14 at 11:56 PM logoMagellan Health, Inc. (MGLN) General Counsel Sells $1,170,813.76 in Stock - September 14 at 4:31 PM logoMagellan Rx Management’s Second Annual Medicaid Trend Report Highlights Opportunities for More Innovative State Specialty Drug Management - September 14 at 7:43 AM logoMagellan Health to Present at the Cantor Fitzgerald Global Healthcare Conference - September 14 at 7:43 AM logoInsider Selling: Magellan Health, Inc. (MGLN) General Counsel Sells 2,400 Shares of Stock - September 12 at 1:30 PM logoMagellan Health, Inc. (MGLN) CEO Mostafa Kamal Sells 670 Shares - September 12 at 1:30 PM logoMostafa Kamal Sells 6,267 Shares of Magellan Health, Inc. (MGLN) Stock - September 11 at 1:20 PM logoCritical Analysis: WellCare Health Plans (WCG) vs. Magellan Health (MGLN) - September 8 at 6:10 PM logoMagellan Health, Inc. (MGLN) CEO Sells $177,543.30 in Stock - September 8 at 4:22 PM logoMagellan Health Provides Free Counseling Services and Referrals to Puerto Rico, Florida Local Community Resources to Individuals Impacted by Hurricane Irma - September 7 at 5:14 AM logoAnalyzing Magellan Health (MGLN) and Humana (HUM) - September 6 at 10:24 PM logoMagellan Health (MGLN) vs. Catamaran Corp (CTRX) Financial Analysis - September 6 at 10:22 PM logoMagellan Health (MGLN) vs. Humana (HUM) Financial Analysis - September 5 at 4:12 AM logoComparing Catamaran Corp (SXCI) and Magellan Health (MGLN) - August 27 at 10:28 AM logoMagellan Health (MGLN) versus Universal American (UAM) Critical Survey - August 26 at 10:08 PM logoMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by Hurricane Harvey - August 26 at 7:09 AM logoMagellan Health, Inc. (MGLN) Given Consensus Recommendation of "Buy" by Brokerages - August 23 at 4:56 PM logoMagellan Health (MGLN) & Catamaran Corp (SXCI) Head-To-Head Review - August 19 at 6:28 PM



Magellan Health (MGLN) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.